Looking toward dividend payers is a particularly good idea, because companies that consistently increase their payouts tend ...

Amgen Inc. is at least fairly valued, with improving balance sheet metrics and a robust growth pipeline offsetting looming ...

The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...